COVID-19-associated mucormycosis involving the maxilla.

It is important to increase the awareness and knowledge of head and neck surgeons about the recent surge of craniofacial mucormycosis in COVID-19 patients because early diagnosis and appropriate treatment are essential to improve the outcomes. Here, we describe clinical features, treatment protocols, and outcomes of treatment in eight patients with COVID-19-associated mucormycosis in the maxilla. Consistent with the findings of previous studies, our experience in the management of these eight patients shows that early administration of amphotericin B and prompt aggressive surgery are essential for optimal control of the disease.

Displacement of the third molar bud to the sublingual space during open reduction and internal fixation of mandibular angle fracture: A case report.

This case could remind surgeons to consider the possibility of displacement of the impacted third molar in the fractured line to adjacent spaces, during open reduction and internal fixation of mandibular angle fracture.